Press Releases
Stay informed with the latest news and updates from the California Institute for Regenerative Medicine (CIRM). For media inquiries or additional information, contact the CIRM communications team at press@cirm.ca.gov. For even more breaking news, visit our blog, The Stem Cellar.
January 31, 2025
CIRM Awards Nearly $100 Million to Boost Discovery, Translational, and Clinical Disease Research
CIRM Awards Nearly $100 Million to Boost Discovery, Translational, and Clinical Disease Research
August 30, 2024
CIRM Awards $67.5 Million to Address Neuropsychiatric Diseases through its ReMIND Program
CIRM Awards $67.5 Million to Address Neuropsychiatric Diseases through its ReMIND Program
June 28, 2024
CIRM awards $26 million to advance clinical research across cancer, heart conditions, and rare diseases
CIRM awards $26 million to advance clinical research across cancer, heart conditions, and rare diseases
May 30, 2024
CIRM funds clinical research in heart failure and cystic fibrosis, supports 10 new translational projects
CIRM funds clinical research in heart failure and cystic fibrosis, supports 10 new translational projects
March 29, 2024
CIRM invests $25 million for discovery and preclinical research, Patient Support Program
CIRM invests $25 million for discovery and preclinical research, Patient Support Program
February 23, 2024
CIRM awards more than $56 Million to advance clinical research, including a novel therapy designed to treat Parkinson’s
CIRM awards more than $56 Million to advance clinical research, including a novel therapy designed to treat Parkinson’s
January 29, 2024
CIRM invests $26 million in clinical-stage research, including Phase 2b trial for bipolar depression
CIRM invests $26 million in clinical-stage research, including Phase 2b trial for bipolar depression
December 6, 2023
CIRM invests $17.5 million in clinical-stage research, including Phase 2 spina bifida trial
CIRM invests $17.5 million in clinical-stage research, including Phase 2 spina bifida trial
October 26, 2023
CIRM-Funded Program Targeting Rare Pediatric Disease Announces FDA Acceptance of Biologics License Application with Priority Review
CIRM-Funded Program Targeting Rare Pediatric Disease Announces FDA Acceptance of Biologics License Application with Priority Review
October 2, 2023
California’s Stem Cell Agency approves new plan to invest $110M into basic research in neuropsychiatric diseases
California’s Stem Cell Agency approves new plan to invest $110M into basic research in neuropsychiatric diseases
September 29, 2023
CIRM invests $44 million to advance regenerative medicine research and manufacturing in California
CIRM invests $44 million to advance regenerative medicine research and manufacturing in California
May 31, 2023
CIRM invests $10 million to build California Cell and Gene Therapy Manufacturing Network
CIRM invests $10 million to build California Cell and Gene Therapy Manufacturing Network
February 27, 2023
California stem cell and gene therapy agency investing in clinical trial for knee osteoarthritis
California stem cell and gene therapy agency investing in clinical trial for knee osteoarthritis
December 15, 2022
Stem Cell & Gene Therapy Agency Funds Clinical Trial to Make Cancer Therapy Safer and Less Toxic
Stem Cell & Gene Therapy Agency Funds Clinical Trial to Make Cancer Therapy Safer and Less Toxic
November 29, 2022
Stem Cell and Gene Therapy Agency Funds Clinical Trials Targeting Solid Tumors, and to Make Kidney Transplants Easier for Patients
Stem Cell and Gene Therapy Agency Funds Clinical Trials Targeting Solid Tumors, and to Make Kidney Transplants Easier for Patients
October 3, 2022
Judy Chou, Ph.D., Appointed to Governing Board of California’s Stem Cell & Gene Therapy Agency
Judy Chou, Ph.D., Appointed to Governing Board of California’s Stem Cell & Gene Therapy Agency
September 29, 2022
State Stem Cell & Gene Therapy Agency Sets up Support Program to Help Patients Participate in Clinical Trials
State Stem Cell & Gene Therapy Agency Sets up Support Program to Help Patients Participate in Clinical Trials
September 20, 2022
Stem Cell and Gene Therapy Agency Funds Clinical Trial for a Functional Cure for HIV
Stem Cell and Gene Therapy Agency Funds Clinical Trial for a Functional Cure for HIV
July 28, 2022
CIRM Board Approves Funding for Clinical Trial Targeting Painful Scarring of the Urethra
CIRM Board Approves Funding for Clinical Trial Targeting Painful Scarring of the Urethra
June 23, 2022
Stem Cell Agency Board Invests in 19 Discovery Research Programs Targeting Cancers, Heart Disease and Other Disorders
Stem Cell Agency Board Invests in 19 Discovery Research Programs Targeting Cancers, Heart Disease and Other Disorders
April 19, 2022
Stem Cell Agency Invests in Therapy Using Killer Cells to Target Colorectal, Breast and Ovarian Cancers
Stem Cell Agency Invests in Therapy Using Killer Cells to Target Colorectal, Breast and Ovarian Cancers
February 14, 2022
CIRM-Funded Study Helping Babies Battle a Deadly Immune Disorder Gets Boost from FDA
CIRM-Funded Study Helping Babies Battle a Deadly Immune Disorder Gets Boost from FDA
January 27, 2022
Stem Cell Agency Board Approves Two Early-Stage Research Programs Targeting Cartilage Damage
Stem Cell Agency Board Approves Two Early-Stage Research Programs Targeting Cartilage Damage
January 24, 2022
California Institute for Regenerative Medicine and the Davos Alzheimer’s Collaborative Release a Statement of Interest to Advance Brain Research
California Institute for Regenerative Medicine and the Davos Alzheimer’s Collaborative Release a Statement of Interest to Advance Brain Research
